Drug Profile
Interleukin-4/13 Trap - Regeneron
Alternative Names: IL-4/13 antagonist - Regeneron; IL-4/13 Trap - Regeneron; Interleukin-4/13 antagonist - RegeneronLatest Information Update: 27 Aug 2007
Price :
$50
*
At a glance
- Originator Regeneron Pharmaceuticals
- Class
- Mechanism of Action Interleukin 13 inhibitors; Interleukin 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma; Hypersensitivity
Most Recent Events
- 03 Mar 2005 This compound is still in active development
- 31 Oct 2002 Phase-I clinical trials in Allergy in USA (unspecified route)
- 31 Oct 2002 Phase-I clinical trials in Asthma in USA (unspecified route)